JP2017537625A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017537625A5 JP2017537625A5 JP2017529381A JP2017529381A JP2017537625A5 JP 2017537625 A5 JP2017537625 A5 JP 2017537625A5 JP 2017529381 A JP2017529381 A JP 2017529381A JP 2017529381 A JP2017529381 A JP 2017529381A JP 2017537625 A5 JP2017537625 A5 JP 2017537625A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- medium
- activator
- cell
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 17
- 210000001744 T-lymphocyte Anatomy 0.000 claims 13
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 4
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 4
- 239000012190 activator Substances 0.000 claims 4
- 239000002609 medium Substances 0.000 claims 4
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 4
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims 2
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical group O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 230000001093 anti-cancer Effects 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 229960000684 cytarabine Drugs 0.000 claims 2
- 229940127089 cytotoxic agent Drugs 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000012636 effector Substances 0.000 claims 2
- 239000012894 fetal calf serum Substances 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 230000003211 malignant effect Effects 0.000 claims 2
- 230000001737 promoting effect Effects 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 1
- 229940122361 Bisphosphonate Drugs 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 1
- 102000000588 Interleukin-2 Human genes 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 150000004663 bisphosphonates Chemical group 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 210000003162 effector t lymphocyte Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 239000012679 serum free medium Substances 0.000 claims 1
- XRASPMIURGNCCH-UHFFFAOYSA-N zoledronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 claims 1
- 229960004276 zoledronic acid Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1421716.0A GB201421716D0 (en) | 2014-12-05 | 2014-12-05 | Cell expansion procedure |
| GB1421716.0 | 2014-12-05 | ||
| PCT/GB2015/053713 WO2016087871A1 (en) | 2014-12-05 | 2015-12-04 | Gammadelta t cell expansion procedure |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017537625A JP2017537625A (ja) | 2017-12-21 |
| JP2017537625A5 true JP2017537625A5 (https=) | 2019-01-17 |
| JP6802159B2 JP6802159B2 (ja) | 2020-12-16 |
Family
ID=52425560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017529381A Active JP6802159B2 (ja) | 2014-12-05 | 2015-12-04 | ガンマデルタt細胞増殖手順 |
Country Status (13)
| Country | Link |
|---|---|
| US (5) | US10557117B2 (https=) |
| EP (2) | EP3696263A1 (https=) |
| JP (1) | JP6802159B2 (https=) |
| KR (1) | KR102686005B1 (https=) |
| CN (1) | CN107208061B (https=) |
| AU (1) | AU2015356788B2 (https=) |
| CA (1) | CA2969783C (https=) |
| DK (1) | DK3227435T3 (https=) |
| GB (1) | GB201421716D0 (https=) |
| MX (1) | MX392057B (https=) |
| RU (1) | RU2017121191A (https=) |
| WO (1) | WO2016087871A1 (https=) |
| ZA (1) | ZA201704499B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201421716D0 (en) | 2014-12-05 | 2015-01-21 | King S College London | Cell expansion procedure |
| KR102032354B1 (ko) * | 2016-11-11 | 2019-10-16 | 가톨릭대학교 산학협력단 | 신규한 배양보조세포 및 이를 이용한 감마 델타 t 세포의 증식 방법 |
| DE102017127984B4 (de) | 2017-11-27 | 2019-12-05 | Immatics US, Inc. | Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen |
| CN108588023B (zh) | 2018-05-09 | 2020-02-14 | 河北森朗生物科技有限公司 | 一种生产嵌合抗原受体修饰的γδT细胞的方法 |
| TW202020145A (zh) | 2018-07-13 | 2020-06-01 | 國立大學法人京都大學 | γδT細胞的製造方法 |
| CA3114292A1 (en) * | 2018-09-27 | 2020-04-02 | Phosphogam, Inc. | Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells |
| CN109234236A (zh) * | 2018-09-29 | 2019-01-18 | 吉林大学第医院 | 一种嵌合抗原受体γδT细胞的制备方法 |
| SG11202104692VA (en) * | 2018-11-08 | 2021-06-29 | In8Bio Inc | Compositions and methods for treating cancer |
| CN110184240B (zh) * | 2019-06-13 | 2020-11-20 | 上海市肺科医院 | 一种高效扩增活化Vγ2Vδ2 T细胞增强其抗结核活性的方法 |
| CA3162755A1 (en) | 2019-11-25 | 2021-06-03 | Kyoto University | T-cell master cell bank |
| US11999968B2 (en) | 2021-10-22 | 2024-06-04 | Fullhope Biomedical Co., Ltd | Modified T cells, pharmaceutical composition, manufacturing method thereof, and method of using the same |
| KR20230105166A (ko) * | 2022-01-03 | 2023-07-11 | 주식회사 이뮤노맥스 | 감마-델타 t 세포의 증식 배양 방법 |
| CN114645022B (zh) * | 2022-05-13 | 2022-09-02 | 首都医科大学宣武医院 | 靶向CD5的CAR-γ δ T细胞及其制备方法与应用 |
| JP2025064863A (ja) * | 2023-10-06 | 2025-04-17 | 株式会社マイオリッジ | T細胞の培養方法 |
| JP7725011B1 (ja) * | 2024-02-01 | 2025-08-19 | ミヤリサン製薬株式会社 | Cd4-cd8-t細胞を増殖および/または活性化させるための組成物 |
| CN120924492B (zh) * | 2025-10-15 | 2026-03-03 | 瑞因细胞工程科技(广州)有限公司 | 一种脐血来源γδT细胞的体外诱导组合物及培养方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7256498A (en) | 1997-04-25 | 1998-11-24 | Wistar Institute Of Anatomy And Biology, The | Cytolytic t-cell clones against colorectal carcinoma and methods of use thereof |
| AU747767B2 (en) * | 1997-11-05 | 2002-05-23 | University Of Southern California | Use of cytokines and mitogens to inhibit pathological immune responses |
| ATE421573T1 (de) * | 1998-11-04 | 2009-02-15 | Therapure Biopharma Inc | Verfahren zur herstellung von gamma delta t zellen |
| US20030157060A1 (en) * | 2000-04-03 | 2003-08-21 | Bell David N | Production of tcr gamma delta t cells |
| FR2836483B1 (fr) | 2002-02-22 | 2006-09-15 | Innate Pharma | Procedes de production de lymphocytes gamma delta t |
| EP1426052B1 (en) | 2002-12-02 | 2009-09-02 | Innate Pharma | Compositions comprising interleukin-2 and gamma-delta T cell activator and uses thereof |
| EP1720567A2 (en) | 2004-02-10 | 2006-11-15 | Innate Pharma | Composition and method for the treatment of carcinoma |
| WO2006006720A1 (ja) * | 2004-07-13 | 2006-01-19 | Medinet., Co.Ltd | γδT細胞の培養方法、γδT細胞及び治療・予防剤 |
| DE602005022728D1 (de) * | 2004-08-19 | 2010-09-16 | Univ Cardiff | Präparation antigenpräsentierender menschlicher gamma delta t-zellen und verwendung in der immuntherapie |
| AU2006272647A1 (en) | 2005-07-25 | 2007-02-01 | Therimunex Pharmaceuticals, Inc. | Peptidyl diacylglycerides |
| WO2008059052A1 (en) * | 2006-11-17 | 2008-05-22 | Innate Pharma | Improved methods of using phosphoantigen for the treatment of cancer |
| WO2008129874A1 (ja) * | 2007-04-13 | 2008-10-30 | Medinet Co., Ltd. | 腫瘍細胞の標的化方法、及びその用途 |
| ITRM20070437A1 (it) * | 2007-08-10 | 2009-02-11 | Istituto Naz Per Le Malattie I | Metodo per la generazione ed espansione di cellule t gamma/delta regolatorie cellule cosi' ottenute e loro impieghi |
| WO2009131730A2 (en) | 2008-01-31 | 2009-10-29 | University Of Iowa Research Foundation | IMMUNOGENIC COMPOSITIONS FOR ACTIVATING γδ T CELLS |
| US8962313B2 (en) * | 2008-07-01 | 2015-02-24 | Medinet Co., Ltd. | Method for the simultaneous induction of CTL and γδT cell |
| US8828944B2 (en) | 2010-04-22 | 2014-09-09 | Institut Gustave Roussy | Compounds and uses thereof to induce an immunogenic cancer cell death in a subject |
| WO2012131419A1 (en) * | 2011-03-25 | 2012-10-04 | Txcell | Method for using regulatory t cells in therapy |
| US10584158B2 (en) | 2013-04-17 | 2020-03-10 | Baylor College Of Medicine | Immunosuppressive TGF-β signal converter |
| CN103436492B (zh) * | 2013-08-02 | 2016-03-02 | 北京赛诺泰生物科技有限公司 | 通过无血清培养扩增活化淋巴细胞的方法 |
| CN103436493B (zh) * | 2013-08-29 | 2016-02-03 | 浙江大学 | 雷帕霉素诱导调节性γδT细胞的培养方法 |
| GB201421716D0 (en) | 2014-12-05 | 2015-01-21 | King S College London | Cell expansion procedure |
-
2014
- 2014-12-05 GB GBGB1421716.0A patent/GB201421716D0/en not_active Ceased
-
2015
- 2015-12-04 MX MX2017007214A patent/MX392057B/es unknown
- 2015-12-04 EP EP20152991.4A patent/EP3696263A1/en not_active Withdrawn
- 2015-12-04 CN CN201580072217.6A patent/CN107208061B/zh active Active
- 2015-12-04 WO PCT/GB2015/053713 patent/WO2016087871A1/en not_active Ceased
- 2015-12-04 EP EP15819849.9A patent/EP3227435B1/en active Active
- 2015-12-04 RU RU2017121191A patent/RU2017121191A/ru not_active Application Discontinuation
- 2015-12-04 CA CA2969783A patent/CA2969783C/en active Active
- 2015-12-04 DK DK15819849.9T patent/DK3227435T3/da active
- 2015-12-04 JP JP2017529381A patent/JP6802159B2/ja active Active
- 2015-12-04 AU AU2015356788A patent/AU2015356788B2/en active Active
- 2015-12-04 US US15/532,921 patent/US10557117B2/en active Active
- 2015-12-04 KR KR1020177018323A patent/KR102686005B1/ko active Active
-
2017
- 2017-07-03 ZA ZA2017/04499A patent/ZA201704499B/en unknown
-
2019
- 2019-12-18 US US16/719,625 patent/US20200140816A1/en not_active Abandoned
- 2019-12-18 US US16/719,650 patent/US11566222B2/en active Active
-
2023
- 2023-01-23 US US18/158,146 patent/US20230323298A1/en not_active Abandoned
-
2024
- 2024-11-29 US US18/964,041 patent/US20250092364A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017537625A5 (https=) | ||
| RU2017121191A (ru) | Методика размножения гамма-дельта Т-клеток | |
| JP2021511790A5 (https=) | ||
| CN105238754B (zh) | 一种高增殖力和高杀伤力nk细胞的体外培养方法 | |
| MY177268A (en) | Medium system and method for ex vivo expansion of nk cells | |
| AR015926A1 (es) | Celulas modificadas geneticamente y su utilizacion en la profilaxis o terapia de enfermedades | |
| JP2004536615A5 (https=) | ||
| FI3578201T3 (fi) | Menetelmiä ja koostumuksia luonnollisille tappajasoluille | |
| CN102356154A (zh) | 从脐带血有效增殖和分化自然杀伤细胞的方法 | |
| JP2019520061A5 (https=) | ||
| WO2001038494A1 (en) | Method of proliferating natural killer cells | |
| CN105219713A (zh) | 用于肿瘤过继性免疫的高增殖力、高杀伤力nk细胞 | |
| JPWO2019044753A1 (ja) | 線維化抑制作用を有する細胞シート | |
| JP2013507945A5 (https=) | ||
| CN115210363B (zh) | 用于增强干细胞功能的组合物 | |
| MX2011000993A (es) | Metodo para separar celulas madre activas de celulas madre humanas y celulas madre altamente activas separadas por el mismo. | |
| ATE349513T1 (de) | Verfahren zur homogenen masskultivierung von t- lymphozyten | |
| CN113679741B (zh) | 人羊膜上皮干细胞在制备治疗顺铂诱导的急性肾损伤的药物中的应用 | |
| JP5751277B2 (ja) | Nk細胞活性化方法、これを用いたnk細胞増殖方法及び細胞製造方法並びにnk細胞を含む単核球 | |
| Adibi et al. | Synthesis of 4-aryl-4H-chromene derivatives with boric acid: evaluation of their in vitro anti-angiogenesis effects and possible mechanism of action | |
| RU2008131594A (ru) | Аутологичная вакцина для лечения онкологических заболеваний и способ ее получения | |
| JP7828098B2 (ja) | T細胞をnk様細胞にリプログラミングする誘導剤およびその使用 | |
| KR101832133B1 (ko) | 폐암세포의 분리 및 증식 방법 | |
| CN113373108A (zh) | 一种表皮干细胞扩增培养基及其制备方法和应用 | |
| RU2526811C1 (ru) | Способ местного лечения ран с помощью биологической повязки, содержащей живые клетки линии диплоидных фибробластов человека |